CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- 4 Grant or award Chief Executive Officer acquired 55,200 shares (grant or award)
- 4 Planned sale Chief Legal Officer sold 1,000 shares at $69.74 ($69,740)
- 4 Planned sale Chief Legal Officer sold 6,500 shares at an average $78.69 ($511,472)
- 4 Exercise or conversion Chief Medical Officer acquired 3,143 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 12,300 shares (option exercise)
- 4 Open-market sale Director sold 754 shares at $91.47 ($68,968)
- 4 Open-market sale Director sold 184,123 shares at an average $91.56 ($16,858,639)
- 4 Planned sale Chief Medical Officer sold 13,093 shares at an average $91.22 ($1,194,372)
- 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $93.05 ($3,721,931)
- 4 Planned sale Chief Operating Officer sold 30,000 shares at an average $84.70 ($2,540,923)
- 4 Open-market sale 10% owner sold 744,047 shares at $80.47 ($59,873,462)
- 4 Open-market sale Director sold 93,585 shares at an average $85.97 ($8,045,252)
- 4 Open-market sale Director sold 90,000 shares at an average $70.14 ($6,312,501)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Executive Officer acquired 10,000 shares (option exercise)
- 4 Planned sale Director sold 2,287 shares at $61.03 ($139,576)
- 4 Planned sale Director sold 32,174 shares at an average $61.11 ($1,966,286)
- 4 Planned sale Director sold 395 shares at $60.95 ($24,075)
- 4 Planned sale Director sold 8,492 shares at $61.04 ($518,352)
- 4 Open-market sale Director sold 42,870 shares at an average $61.03 ($2,616,391)
Page 3 of 15 · 283 filings